Home › Compare › FIRRX vs JNJ

FIRRX vs JNJ: Dividend Comparison 2026

FIRRX yields 1.24% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 FIRRX wins by $1.4K in total portfolio value
10 years
FIRRX
FIRRX
● Live price
1.24%
Share price
$51.74
Annual div
$0.64
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.5K
Annual income
$134.93
Full FIRRX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — FIRRX vs JNJ

📍 FIRRX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodFIRRXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, FIRRX + JNJ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
FIRRX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

FIRRX
Annual income on $10K today (after 15% tax)
$105.80/yr
After 10yr DRIP, annual income (after tax)
$114.69/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $588.92/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of FIRRX + JNJ for your $10,000?

FIRRX: 50%JNJ: 50%
100% JNJ50/50100% FIRRX
Portfolio after 10yr
$20.7K
Annual income
$481.36/yr
Blended yield
2.32%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

FIRRX
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

FIRRX buys
0
JNJ buys
0
No recent congressional trades found for FIRRX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricFIRRXJNJ
Forward yield1.24%3.36% ✓
Annual dividend / share$0.64$4.96 ✓
Payout ratio50% ✓55%
1-year div growth0%4.2% ✓
5-year div CAGR0%5.8% ✓
Portfolio after 10y$21.5K ✓$20.0K
Annual income after 10y$134.93$827.78 ✓
Total dividends collected$1.3K$5.6K ✓
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: FIRRX vs JNJ ($10,000, DRIP)

YearFIRRX PortfolioFIRRX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,824$124.47$10,676$355.77+$148.00 → FIRRX
2$11,708$125.92$11,407$389.39+$301.00 → FIRRX
3$12,655$127.29$12,198$426.53+$457.00 → FIRRX
4$13,669$128.58$13,056$467.62+$613.00 → FIRRX
5$14,756$129.80$13,987$513.12+$769.00 → FIRRX
6$15,920$130.95$14,998$563.56+$922.00 → FIRRX
7$17,166$132.04$16,098$619.52+$1.1K → FIRRX
8$18,501$133.06$17,295$681.69+$1.2K → FIRRX
9$19,930$134.02$18,599$750.82+$1.3K → FIRRX
10$21,460$134.93$20,022$827.78+$1.4K → FIRRX

FIRRX vs JNJ: Complete Analysis 2026

FIRRX — Stock

The fund invests in a combination of Fidelity U.S. equity funds, international equity funds, bond funds, and short-term funds to seek to achieve the fund's investment objective consistent with a payment strategy to be administered through a complementary systematic withdrawal plan.

Full FIRRX Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this FIRRX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

FIRRX vs SCHDFIRRX vs JEPIFIRRX vs OFIRRX vs KOFIRRX vs MAINFIRRX vs ABBVFIRRX vs MRKFIRRX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.